Illumina

Associate Director Government Affairs

Saudi Arabia

Auto‑apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, HealthcareIndustries

Requirements

The Associate Director Government Affairs Middle East, with focus on Saudi Arabia, will drive the development and implementation of corporate policy through strategic partnerships with government and industry groups aligning with business objectives to advance Illumina’s mission in the region. They will serve as the organization’s contact for legislative and public policy matters and will establish key partnerships with government ministries, regulators such as Ministry of Health, MISA, Saudi Food & Drug Authority (SFDA), and other relevant stakeholders in Saudi Arabia and the region. The successful candidate will develop and execute government affairs strategies to support Illumina’s business objectives in Saudi Arabia and the Middle East, monitor and analyze regulatory and policy developments, and advocate for policies that foster innovation and market access.

Responsibilities

This role involves preparing policy briefings and providing thought leadership and recommendations, ensuring appropriate company participation in government forums and industry group meetings, collaborating with internal teams to align government engagement efforts with business priorities, frequently interacting with senior management and/or executives, and supporting strategic partnerships with public and private sector stakeholders to advance national genomics initiatives and precision medicine programs. The Associate Director will also lead public affairs initiatives to enhance Illumina’s visibility and frequently interact with stakeholders to influence public policy and preserve relationships.

Skills

Government Affairs

Public Policy

Strategic Partnerships

Policy Briefings

Legislative Liaison

Stakeholder Engagement

Policy Advocacy

Industry Relations

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free